Analyst Consensus ?
ConsensusBuy37 ratings
Bullish2875.7%
Neutral924.3%
Bearish00.0%
FN2 Earnings Intelligence
Newmont Corporation complete analyst coverage
Newmont Corporation (NEM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$91.52Current
$57Low
$105.66Average
$177High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Jul 16, 2026 |
| TD Cowen | Buy | Hold | Upgrade | Jul 14, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Jul 14, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 9, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 9, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 6, 2026 |
| UBS | Buy | Buy | Maintain | Jun 30, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 24, 2026 |
| CIBC | Outperform | Outperform | Maintain | Apr 21, 2026 |
| Citigroup | Buy | Buy | Maintain | Mar 3, 2026 |
| Bernstein | Market Outperform | Market Perform | Upgrade | Feb 27, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Sep 30, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Sep 23, 2025 |
| Macquarie | Neutral | Outperform | Downgrade | Sep 2, 2025 |
| JP Morgan | Overweight | Neutral | Upgrade | Nov 19, 2024 |
| Argus Research | Buy | Hold | Upgrade | Aug 29, 2024 |
| TD Securities | Hold | Hold | Maintain | Apr 29, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 21, 2023 |
| Canaccord Genuity | Buy | Hold | Upgrade | Mar 14, 2023 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Feb 13, 2023 |
| Credit Suisse | Neutral | Outperform | Downgrade | Apr 19, 2022 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 17, 2020 |
| B. Riley Securities | Buy | Buy | Maintain | May 19, 2020 |
| B. Riley FBR | Buy | Buy | Maintain | May 19, 2020 |
| B. Riley | Buy | Neutral | Upgrade | Jan 13, 2020 |
| Citi | Buy | Neutral | Upgrade | May 23, 2019 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jun 12, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Bank of America | Buy | Buy | Maintain | Feb 26, 2018 |
| Standpoint Research | Buy | Hold | Upgrade | Dec 29, 2016 |
| Mackie Research | Buy | Hold | Upgrade | Oct 31, 2016 |
| Clarksons Platou | Neutral | Buy | Downgrade | Apr 18, 2016 |
| Clarkson Capital Markets | Neutral | Buy | Downgrade | Apr 18, 2016 |
| FBR Capital | Market Perform | Market Perform | Maintain | Jan 28, 2016 |
| HSBC | Hold | Buy | Downgrade | Oct 26, 2015 |
| BB&T Capital | Hold | Buy | Downgrade | Nov 3, 2014 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Sep 9, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $91.52. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| CIBC | Anita Soni | $168 | $91.64 | +83.6% | Jul 28, 2026 |
| Barclays | Richard Garchitorena | $124 | $93.47 | +35.5% | Jul 28, 2026 |
| Barclays | Analyst unavailable | $125 | $95.04 | +36.6% | Jul 15, 2026 |
| Scotiabank | Analyst unavailable | $147 | $94.88 | +60.6% | Jul 14, 2026 |
| RBC Capital | Josh Wolfson | $135 | $94.52 | +47.5% | Jul 9, 2026 |
| Jefferies | Analyst unavailable | $146 | $97.04 | +59.5% | Jul 6, 2026 |
| UBS | Analyst unavailable | $120 | $92.34 | +31.1% | Jun 30, 2026 |
| CIBC | Anita Soni | $175 | $107.23 | +91.2% | Jun 1, 2026 |
| Barclays | Analyst unavailable | $133 | $108.33 | +45.3% | May 21, 2026 |
| TD Securities | Steven Green | $129 | $120.7 | +41.0% | Apr 27, 2026 |
| BMO Capital | Matthew Murphy | $145 | $117.87 | +58.4% | Apr 24, 2026 |
| CIBC | Anita Soni | $176 | $110.51 | +92.3% | Apr 21, 2026 |
| National Bank | Shane Nagle | $130 | $113.41 | +42.0% | Apr 16, 2026 |
| UBS | Analyst unavailable | $140 | $102.1 | +53.0% | Mar 27, 2026 |
| BMO Capital | Matthew Murphy | $140 | $121.02 | +53.0% | Feb 20, 2026 |
| Stifel Nicolaus | Analyst unavailable | $175 | $120.39 | +91.2% | Feb 10, 2026 |
| CIBC | Analyst unavailable | $177 | $114.36 | +93.4% | Feb 4, 2026 |
| UBS | Analyst unavailable | $160 | $117.25 | +74.8% | Jan 30, 2026 |
| Scotiabank | Analyst unavailable | $152 | $128.69 | +66.1% | Jan 26, 2026 |
| Raymond James | Analyst unavailable | $111 | $100.47 | +21.3% | Dec 29, 2025 |
| Jefferies | Fahad Tariq | $120 | $89.76 | +31.1% | Dec 7, 2025 |
| BNP Paribas | Analyst unavailable | $97 | $90.72 | +6.0% | Dec 5, 2025 |
| UBS | Daniel Major | $125 | $91.82 | +36.6% | Dec 1, 2025 |
| Raymond James | Brian MacArthur | $99 | $83.31 | +8.2% | Oct 24, 2025 |
| Scotiabank | Analyst unavailable | $114 | $87.01 | +24.6% | Oct 23, 2025 |
| UBS | Analyst unavailable | $105.5 | $93.58 | +15.3% | Oct 16, 2025 |
| Goldman Sachs | Analyst unavailable | $104.3 | $85.14 | +14.0% | Oct 12, 2025 |
| Raymond James | Brian MacArthur | $96 | $85.21 | +4.9% | Oct 10, 2025 |
| CIBC | Analyst unavailable | $112 | $85.21 | +22.4% | Oct 10, 2025 |
| RBC Capital | Josh Wolfson | $95 | $75.92 | +3.8% | Sep 9, 2025 |
| Macquarie | Andrew Bowler | $72 | $74.4 | -21.3% | Sep 1, 2025 |
| CIBC | Anita Soni | $74 | $57.35 | -19.1% | Jul 15, 2025 |
| Argus Research | John Eade | $63 | $53.68 | -31.2% | Apr 25, 2025 |
| Raymond James | Analyst unavailable | $66 | $53.94 | -27.9% | Apr 25, 2025 |
| UBS | Daniel Major | $54 | $47.8 | -41.0% | Oct 30, 2024 |
| RBC Capital | Josh Wolfson | $53 | $57.74 | -42.1% | Oct 24, 2024 |
| Jefferies | Matthew Murphy | $63 | $53.04 | -31.2% | Oct 4, 2024 |
| Jefferies | Matthew Murphy | $54 | $51.3 | -41.0% | Sep 10, 2024 |
| Argus Research | John Eade | $58 | $51.83 | -36.6% | Aug 29, 2024 |
| Scotiabank | Tanya Jakusconek | $59 | $51.19 | -35.5% | Aug 19, 2024 |
| BMO Capital | Jackie Przybylowski | $57 | $47.7 | -37.7% | Jul 25, 2024 |
| CIBC | Anita Soni | $61 | $45.36 | -33.3% | Jul 10, 2024 |
| UBS | Daniel Major | $50 | $40.97 | -45.4% | Jun 17, 2024 |
| Scotiabank | Tanya Jakusconek | $48 | $41.28 | -47.6% | May 23, 2024 |
| Goldman Sachs | Emily Chieng | $67 | $41.02 | -26.8% | Dec 15, 2023 |
| RBC Capital | Josh Wolfson | $60 | $45.61 | -34.4% | Jul 27, 2022 |
| Canaccord Genuity | Carey MacRury | $60 | $46.14 | -34.4% | Jul 26, 2022 |
| Canaccord Genuity | Analyst unavailable | $80 | $73.43 | -12.6% | Apr 26, 2022 |
| Fundamental Research | Siddharth Rajeev | $63.1 | $55.25 | -31.1% | Nov 8, 2021 |
| CIBC | Anita Soni | $69 | $53.09 | -24.6% | Oct 29, 2021 |
| TD Securities | Greg Barnes | $70 | $58.82 | -23.5% | Jul 26, 2021 |
| Desjardins | John Sclodnick | $85.94 | $71.39 | -6.1% | May 20, 2021 |
| Argus Research | David Coleman | $73 | $62.68 | -20.2% | May 5, 2021 |
| BMO Capital | Andrew Kaip | $85 | $60.33 | -7.1% | Apr 30, 2021 |
Track every rating change on NEM the moment it posts. Free to start.
Start free